TyG Index

If you want to know whether your body is quietly becoming resistant to insulin, this number gives you a low-cost window into that process. It uses two values already found on most routine blood panels: fasting triglycerides (a type of blood fat) and fasting blood sugar.

This matters because insulin resistance often builds silently for years before your fasting blood sugar climbs into the diabetes range. Tracking this score can flag that shift while there is still time to act.

What This Number Actually Is

The TyG index (triglyceride-glucose index) is a math formula that combines your fasting triglycerides and fasting blood sugar into a single value. The key validation study establishing it as a stand-in for insulin resistance, which compared it against the gold-standard lab method, was published in 2010.

Its purpose is to stand in for insulin resistance, a state where your cells stop responding well to insulin, the hormone that moves sugar out of your blood and into your cells. The most precise ways to measure insulin resistance involve expensive lab procedures or insulin blood tests. This score sidesteps all of that by using two numbers you can get from a standard fasting blood draw.

Because it blends a blood-fat signal and a blood-sugar signal, it captures the overlap between two problems that tend to travel together: high blood fats and trouble managing blood sugar. When both are elevated, it usually points to insulin resistance and broader metabolic strain across your liver, muscle, and fat tissue.

How Well It Tracks True Insulin Resistance

Against the gold-standard lab method for measuring insulin sensitivity, one validation study found this score did well, correctly flagging about 96 or 97 out of every 100 people with insulin resistance and correctly clearing about 85 out of 100 without it. Earlier work comparing it to a simpler insulin-based calculation was more mixed, catching about 84 out of 100 cases but wrongly flagging many people who did not have the condition.

A systematic review pooling 15 studies and 69,922 participants rated the overall evidence as low-to-moderate quality, with accuracy scores (a measure of how well a test separates people with and without a condition, where 1.0 is perfect and 0.5 is a coin flip) ranging from 0.59 to 0.88. The takeaway: this is a useful stand-in, not a perfect one.

This is a research-grade marker, not a fully standardized clinical test. There is no single agreed-upon cutoff, and thresholds shift by ethnicity, sex, and age. That is exactly why a single reading matters less than your personal trend over time.

Type 2 Diabetes

This is where the evidence is strongest. In a pooled analysis of many studies, people with a high score were about 3.5 times as likely to develop type 2 diabetes. The signal shows up even before blood sugar looks abnormal.

In one study of adults who started with normal fasting blood sugar, those in the top quarter of scores were about 6.87 times as likely to develop diabetes as those in the bottom quarter. In that same group, this score predicted future diabetes better than fasting blood sugar alone (accuracy 0.75 versus 0.66).

What this means for you: a normal fasting glucose does not rule out trouble ahead. If this score is rising, it can surface diabetes risk that a standard glucose reading misses, giving you a head start on prevention.

Heart Attack and Stroke

Across large populations, a higher score tracks with more future heart disease, though the effect for the score alone is usually modest to moderate. In a study of 141,243 adults across 22 countries followed for about 13 years, those in the highest third had roughly 21% higher risk of a combined heart-disease outcome, 24% higher risk of heart attack, and 16% higher risk of stroke than those in the lowest third.

A meta-analysis pooling 12 studies and 6,354,990 participants found the highest scorers had about twice the risk of coronary artery disease (a narrowing of the heart's arteries) and roughly 46% higher risk of a combined heart-disease outcome compared with the lowest scorers. In people who already have stable coronary artery disease, each one-standard-deviation rise in the score was linked to about 23% higher risk of heart events.

The heart-disease link is not uniform everywhere. In the 22-country study, the connection to heart events and death was strongest in low- and middle-income countries, while in high-income countries a higher score mainly predicted diabetes rather than heart disease. Population context shapes how much weight to give this number.

Fatty Liver Disease

Elevated triglycerides point toward fat building up where it should not, including in the liver. A meta-analysis found this score identified fatty liver disease with reasonable accuracy (0.75), catching roughly 73 out of 100 cases and correctly clearing roughly 67 out of 100 people without it, though individual studies vary around these approximate values.

A separate meta-analysis of 17 studies and 121,975 people found those with a high score had markedly higher odds of developing fatty liver disease over time. This makes the score a practical early flag for a condition that is often silent until later stages.

Metabolic Syndrome

Metabolic syndrome is a cluster of risk factors including high blood sugar, high blood fats, high blood pressure, and excess belly fat. This score is a strong screening tool for it, with pooled accuracy around 0.87 and roughly 80% sensitivity and specificity in one large analysis.

In several studies it outperformed fasting glucose, triglycerides, and even an insulin-based calculation for spotting metabolic syndrome, with accuracy values around 0.76 to 0.89 in adults.

Kidney and Other Links

A higher score has been tied to chronic kidney disease (about 46% higher risk in pooled evidence) and, in people with type 2 diabetes, to diabetic kidney disease (roughly 70% higher odds). It has also been associated with dementia, cognitive impairment, and obstructive sleep apnea, though these links are less foundational than the core insulin-resistance and diabetes signal.

In a Korean study of 5,586,048 adults followed for about seven years, those in the top quarter had modestly higher dementia risk (about 14% higher) than the bottom quarter, an effect that held after accounting for standard risk factors but was small in size.

Why the Numbers Can Seem to Disagree

You may notice studies reporting wildly different cutoffs, some near 8.5 and others as low as 4.68. This is not a contradiction. There are two common versions of the formula, one that divides the product of triglycerides and glucose by 2 and one that does not, and differences in how units are handled shift the numeric value even when they rank people identically. Before comparing your number to any published threshold, you need to know which formula and units were used.

Adding Body Measurements Sharpens the Signal

Combining this score with a measure of body size, especially waist circumference or waist-to-height ratio, often predicts outcomes better than the score alone. In 11,149 Korean adults, the odds of insulin resistance comparing the top and bottom quarters were about 16-fold for the waist-combined version versus about 7.6-fold for the score by itself.

In 97,331 people with fatty liver disease, the waist-to-height combined version showed the best ability to predict heart disease and death. If your standalone number is borderline, pairing it with your waist measurement can add meaningful information.

Why One Reading Is Not Enough

This score has no universally agreed cutoff, which makes your personal trajectory more valuable than any single value. A baseline gives you a starting point; repeat testing tells you whether your metabolic health is drifting in the wrong direction or responding to change.

Because both inputs, fasting triglycerides and fasting blood sugar, respond to how you eat, move, and sleep, tracking the score over time can show whether an intervention is actually working. Get a baseline, retest in 3 to 6 months if you are making changes, and check at least annually after that.

As a newer measurement without standardized thresholds, getting a baseline now and watching the trend gives you your own data to compare against as the science matures. That is more useful than fixating on whether a single reading crosses someone else's cutoff.

What to Do With an Unexpected Result

A single high number is a prompt to look deeper, not a diagnosis. Retest after a proper fast to confirm, then look at the pattern alongside companion markers: fasting insulin, HbA1c (a measure of average blood sugar over about three months), a full lipid panel, and liver enzymes. A high score combined with a rising HbA1c and an enlarging waist is a stronger signal than any one value alone.

If several of these point the same direction, that is the combination worth acting on, and a good reason to involve a clinician who focuses on metabolic health, such as an endocrinologist. Add your waist measurement to sharpen the picture, and treat the score as one input in a larger metabolic and cardiovascular workup rather than a standalone verdict.